China Cord Blood Corporation (CO)
-NYSE 2.80 0.00(0.00%) 1:23PM EDT - Nasdaq Real Time Price
| Prev Close: | 2.80 |
|---|
| Open: | 2.83 |
|---|
| Bid: | 2.79 x 4200 |
|---|
| Ask: | 2.80 x 5800 |
|---|
| 1y Target Est: | 5.25 |
|---|
| Beta: | 0.62 |
|---|
| Next Earnings Date: | 7-Jun-13 |
|---|
| Day's Range: | 2.79 - 2.84 |
|---|
| 52wk Range: | 2.21 - 3.20 |
|---|
| Volume: | 47,206 |
|---|
| Avg Vol (3m): | 80,979 |
|---|
| Market Cap: | 204.41M |
|---|
| P/E (ttm): | 11.20 |
|---|
| EPS (ttm): | 0.25 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- China Cord Blood: Evaluating Buyout Potentialat Seeking Alpha(Wed, May 1)
- Amedysis Reports 1Q Prelim EarningsZacks(Fri, Apr 26)
- Tuesday Sector Laggards: Hospital & Medical Practitioners, Diagnosticsat Forbes(Tue, Apr 16)
- DaVita Hit 52-Week HighZacks(Wed, Apr 3)
- China Cord Blood Corporation Received AABB AccreditationPR Newswire(Tue, Apr 2)
- EU Executive Insists on Firm Line on Airlines in Carbon Planat Bloomberg(Tue, Mar 19)
- 3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part IIat Seeking Alpha(Mon, Mar 11)
- New Star Analyst Rankings for China Cord Blood Corporation. CStarMine(Wed, Feb 27)
- China Cord Blood's CEO Discusses F3Q 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, Feb 27)
- China Cord Blood Beats on EPS But GAAP Results Lagat Motley Fool(Tue, Feb 26)
- China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013PR Newswire(Tue, Feb 26)
- Q3 2013 China Cord Blood Corp Earnings Release - After Market CloseCCBN(Tue, Feb 26)
- China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial ResultsPR Newswire(Tue, Feb 19)
- China Cord Blood Corporation Announces Completion of Corporate Structure ConsolidationPR Newswire(Thu, Feb 7)
- EU Lawmaker Seeks Clear Rules on Aviation Carbon Curbs Freezeat Bloomberg(Wed, Jan 9)
Key Statistics
| Forward P/E (1 yr): | 14.00 |
|---|
| P/S (ttm): | 2.60 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Mar-13)
: | 0.21 |
|---|
| Quarterly EPS Est
(Mar-13)
: | 0.02 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | 0.46 |
|---|
Business Summary
China Cord Blood Corporation, together with its subsidiaries, engages in the provision of umbilical cord blood storage and ancillary services in the Peoples Republic of China.
View More